Seroconversion

There are 7 papers on seroconversion in aging research: 5 trials and 1 observational study in people, 1 in animals.

Biomarker

7 papers study it46 more mention it2 findings

1 new paper in 30 daysSee all 53 papers on seroconversion

“Seroconversion to the H1N1 subunit in the older subjects was associated with higher post-vaccination numbers of plasma B cells”
Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trialClinical nutrition (Edinburgh, Scotland)2017doi:10.1016/j.clnu.2017.01.011
  • Human trial5
  • Humans1
  • Animals1

Interventions

1

GRAD-COV2

upin humans1

1 study
  1. GRAD-COV2 induces seroconversion in humans (43 of 44 young and 45 of 45 older participants).

    “seroconversion to spike protein and receptor binding domain was achieved in 43 of 44 young volunteers and in 45 of 45 older participants”

    Human trialthree escalating dosesfour weeksn = 90

    GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

    Science translational medicine

More on GRAD-COV2

Associations

1

Plasma B cell

upin humans1

1 study
  1. Plasma B cell is associated with seroconversion in humans (response to seasonal influenza vaccination).

    “Seroconversion to the H1N1 subunit in the older subjects was associated with higher post-vaccination numbers of plasma B cells”

    Humansresponse to seasonal influenza vaccination

    Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trial

    Clinical nutrition (Edinburgh, Scotland)

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 0Nov 2026: 06 papers in 12 months

See all 53 papers on seroconversion